Nipping cytomegalovirus in the bud for umbilical cord blood transplantation.

Published in: British journal of haematology (2024)

Real data confirm an excellent toxicity profile and effectiveness of letermovir prophylaxis with decreased cytomegalovirus reactivation and resistance in umbilical cord blood transplantation for both paediatric and adult patients. Commentary on: Yan et al. Letermovir prophylaxis reduced cytomegalovirus reactivation and resistance post umbilical cord blood transplantation. Br J Haematol 2024;204:2378-2389.

Keyphrases

umbilical cord
mesenchymal stem cells
cell therapy
epstein barr virus
randomized controlled trial
systematic review
bone marrow
emergency department
intensive care unit
oxidative stress
stem cells
big data
machine learning